[The Multicenter Captopril and the Quality of Life Study: the effect of antihypertensive agents from the basic groups on the quality of life of patients in different populations. The working group of the Multicenter Captopril and the Quality of Life Study].
This multicenter trial included 205 males aged 30-60 years with stable mild and moderate hypertension. 140 patients were from Moscow (140 patients), St. Petersburg, Kursk, Rostov (Russia); Kharkov, Donetsk (Ukraine); Baku (Azerbaijan). Group 1 patients received captopril, group 2 nifedipine, group 3 hydrochlorothiazide, group 4 propranolol.
Metelitsa
V I
VI
Duda
S G
SG
Ostrovskaia
T P
TP
Filatova
N P
NP
Mukhamedzhanova
G F
GF
Vygodin
V A
VA
Broer
M
M
Siegrist
I
I
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001382:Azerbaijan; D002216:Captopril / Q000627:therapeutic use*; D003710:Demography; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009031:Moscow; D009543:Nifedipine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011788:Quality of Life; D012426:Russia; D014455:Ukraine; D014505:Urban Population
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D002216:Captopril; D011433:Propranolol; D009543:Nifedipine